论文信息 - Adjuvant therapy in resectable gastric cancer-the CRITICS trial - Authors' reply. - 字舞流文

Adjuvant therapy in resectable gastric cancer-the CRITICS trial - Authors' reply.

K. Sikorska | M. Verheij | A. Cats

[1] H. Putter,et al. Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial. , 2018, The Lancet. Oncology.

[2] M. Verheij. Patterns of recurrence to guide selection of multi-modal treatment. , 2018, European Journal of Cancer.

[3] S. Mocellin,et al. Diagnostic accuracy of endoscopic ultrasonography (EUS) for the preoperative locoregional staging of primary gastric cancer. , 2015, The Cochrane database of systematic reviews.

[4] M. Verheij,et al. Does Adjuvant Chemoradiotherapy Improve the Prognosis of Gastric Cancer After an R1 Resection? Results from a Dutch Cohort Study , 2015, Annals of Surgical Oncology.

[5] H. Putter,et al. Impact of the extent of surgery and postoperative chemoradiotherapy on recurrence patterns in gastric cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.